Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-01-04

FDA Approved: VENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Venlafaxine from Alembic Pharmaceuticals Inc. under an approved ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Venlafaxine (Venlafaxine)

Snippet

SUPPL AP for VENLAFAXINE (VENLAFAXINE)